Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease

Journal of Biomedical Science

Volumn 9, Issue 4, 2002, Pages 303-310

  Chen, Guann Juh ^a   Jeng, Churn Hueih ^b   Lin, Shinn Zong ^a   Tsai, Shin Han ^c   Wang, Yun ^d   Chiang, Yun Hsiao ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Dopamine; Electrophysiology; Huntington's disease; Neural transplantation; Regeneration; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID; APOMORPHINE; DOPAMINE; NEUROTRANSMITTER; QUINOLINIC ACID; TYROSINE 3 MONOOXYGENASE; URETHAN; DOPAMINE RECEPTOR;

ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DRUG DOSE REDUCTION; DRUG INHIBITION; FEMALE; FETAL TISSUE TRANSPLANTATION; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MICROINJECTION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ACTION POTENTIAL; ANIMAL; BRAIN TRANSPLANTATION; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; ELECTROPHYSIOLOGY; GRAFT SURVIVAL; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; ROTATION; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ANIMALIA;

ACTION POTENTIALS; ANIMALS; APOMORPHINE; BRAIN TISSUE TRANSPLANTATION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTROPHYSIOLOGY; FEMALE; FETAL TISSUE TRANSPLANTATION; GAMMA-AMINOBUTYRIC ACID; GRAFT SURVIVAL; HUMANS; HUNTINGTON DISEASE; NEURONS; QUINOLINIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; ROTATION; TYROSINE 3-MONOOXYGENASE;

EID: 0036653659     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1159/000065000     Document Type: Article

References (29)

1. Augood SJ, Faull RL, Emson PC. Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann Neurol 42:215-221;1997.
2. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181-4192;1993.
3. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321:168-171;1986.
4. Bird ED. Chemical pathology of Huntington's disease. Annu Rev Pharmacol Toxicol 20:533-551;1980.
5. Calderon SF, Sanberg PR, Norman AB. Quinolinic acid lesions of rat striatum abolish D1-and D2-dopamine receptor-mediated catalepsy. Brain Res 450:403-407;1988.
6. Clarke DJ, Dunnett SB, Isacson O, Sirinathsinghji DJ, Bjorklund A. Striatal grafts in rats with unilateral neostriatal lesions. 1. Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway. Neuroscience 24:791-801;1988.
7. Coyle JT. An animal model for Huntington's disease. Biol Psychiatry 14:251-276;1979.
8. Gehlert DR, Schoepp DD. Striatal quinolinic acid lesions increase [3H]WIN 35,428 binding to the dopamine transporter. Neurochem Int 21:581-584;1992.
9. Gerhardt GA, Palmer MR. Characterization of the techniques of pressure ejection and microiontophoresis using in vivo electrochemistry. J Neurosci Methods 22:147-159;1987.
10. Graybiel AM, Liu FC, Dunnett SB. Intrastriatal grafts derived from fetal striatal primordia. 1. Phenotypy and modular organization. J Neurosci 9:3250-3271;1989.
11. Helm GA, Robertson MW, Jallo GI, Simmons N, Bennett JPJ. Development of D1 and D2 dopamine receptors and associated second messenger systems in fetal striatal transplants. Exp Neurol 111:181-189;1991.
12. Hu XT, Wachtel SR, Galloway MP, White FJ. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation. J Neurosci 10:2318-2329;1990.
13. Hu XT, Wang RY. Comparison of effects of D1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: An electrophysiological study. J Neurosci 8:4340-4348;1988.
14. Isacson O, Brundin P, Kelly PA, Gage FH, Bjorklund A. Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature 311:458-460;1984.
15. Kopyov OV, Jacques S, Lieberman A, Duma CM, Eagle KS. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 149:97-108;1998.
16. Levivier M, Holemans S, Togasaki DM, Maloteaux JM, Brotchi J, Przedborski S. Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays. Neurol Res 16:194-200;1994.
17. Mayer E, Heavens RP, Sirinathsinghji DJ. Autoradiographic localisation of D1 and D2 dopamine receptors in primordial striatal tissue grafts in rats. Neurosci Lett 109:271-276;1990.
18. Mazzari S, Aldinio C, Beccaro M, Toffano G, Schwarcz R. Intracerebral quinolinic acid injection in the rat: Effects on dopaminergic neurons. Brain Res 380:309-316;1986.
19. Nakao N, Ogura M, Nakai K, Itakura T. Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease. Neuroscience 88:469-477;1999.
20. Norman AB, Calderon SF, Giordano M, Sanberg PR. A novel rotational behavior model for assessing the restructuring of striatal dopamine effector systems: Are transplants sensitive to peripherally acting drugs? Prog Brain Res 78:61-67;1988.
21. Philpott LM, Kopyov OV, Lee AJ, Jacques S, Duma CM, Caine S, Yang M, Eagle KS. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: Three case presentations. Cell Transplant 6:203-212;1997.
22. Pundt LL, Narang N, Kondoh T, Low WC. Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease. Neurosci Res 27:305-315;1997.
23. Sanberg PR, Calderon SF, Giordano M, Tew JM, Norman AB. The quinolinic acid model of Huntington's disease: Locomotor abnormalities. Exp Neurol 105:45-53;1989.
24. Sanberg PR, Zubrycki E, Ragozzino ME, Giordano M, Shipley MT. Tyrosine hydroxylase-positive fibers and neurons in transplanted striatal tissue in rats with quinolinic acid lesions of the striatum. Brain Res Bull 25:889-894;1990.
25. Schultz W, Ungerstedt U. Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behaviour. Neuropharmacology 17:349-353;1978.
26. Shear DA, Dong J, Gundy CD, Haik-Creguer KL, Dunbar GL. Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease. Prog Neuropsychopharmacol Biol Psychiatry 22:1217-1240;1988.
27. Wictorin K, Isacson O, Fischer W, Nothias F, Peschanski M, Bjorklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum. 1. Subcortical afferents. Neuroscience 27:547-562;1988.
28. Zhou FC, Buchwald N. Connectivities of the striatal grafts in adult rat brain: A rich afference and scant striatonigral efference. Brain Res 504:15-30;1989.
29. Zhou FC, Buchwald N, Hull C, Towle A. Neuronal and glial elements of fetal neostriatal grafts in the adult neostriatum. Neuroscience 30:19-31;1989.